Gregory Piazza: Bicuspid Aortic Valve Affects Approximately 2% of The Population
Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, shared on LinkedIn:
”Bicuspid aortic valve affects approximately 2% of the population and is often underdiagnosed and underrecognized as a potential mechanism for valvular heart disease and aortic aneurysm. In our new analysis of the CDC WONDER dataset, mortality seems to be increasing in this population within the US. Great work by our collaborator and master data scientist, Dr. Marco Zuin!”
Read the full article here.
Article: Trends in Bicuspid Aortic Valve–Attributable Death in the United States From 2010 to 2020
Authors: Marco Zuin, Umberto Campia, Kim I. De la Cruz, Michael Singh, Gregory Piazza
Stay updated on all scientific advances with Hemostasis Today.
-
May 22, 2026, 12:25Shehab Mohamed: Exploring the Emerging Link Between JAK2 Mutations and Thoracic Aortic Aneurysms
-
May 22, 2026, 11:52Prakash W. Kamat: Highlighting the Role of Physical Activity in Hemophilia Management
-
May 22, 2026, 11:43Mohamed Hanafy Morsy: Understanding Hemochromatosis – Genetics Made Simple
-
May 22, 2026, 10:23Rucha Patil: Insights from The National Haemophilia Conclave 2026
-
May 22, 2026, 10:11Narat Srivali: New Systematic Review and Meta-Analysis on Glucocorticoid Therapy and The Risk of VTE
-
May 22, 2026, 10:02Greta Mulders: Nursing Leadership in Haemophilia Gene Therapy
-
May 22, 2026, 08:45Dirk Sibbing: Ethnicity and Antiplatelet Therapy Outcomes in CCS
-
May 22, 2026, 08:35Jason Brandon: On Lyophilized Hemostatic Supplementation at Simmons Research Day 2026
-
May 22, 2026, 08:28Inconsistent D-Dimer Assay Reporting in VTE Studies – JTH